nodes	percent_of_prediction	percent_of_DWPC	metapath
Bexarotene—CYP3A4—Temozolomide—melanoma	0.113	0.576	CbGbCtD
Bexarotene—CYP3A4—Vemurafenib—melanoma	0.0618	0.316	CbGbCtD
Bexarotene—CYP3A4—Docetaxel—melanoma	0.0212	0.108	CbGbCtD
Bexarotene—Oedema peripheral—Temozolomide—melanoma	0.000956	0.00193	CcSEcCtD
Bexarotene—Pruritus—Vemurafenib—melanoma	0.000955	0.00192	CcSEcCtD
Bexarotene—Connective tissue disorder—Temozolomide—melanoma	0.000954	0.00192	CcSEcCtD
Bexarotene—Lethargy—Docetaxel—melanoma	0.000952	0.00192	CcSEcCtD
Bexarotene—Urethral disorder—Temozolomide—melanoma	0.000951	0.00192	CcSEcCtD
Bexarotene—Alopecia—Dactinomycin—melanoma	0.000948	0.00191	CcSEcCtD
Bexarotene—Eye disorder—Carmustine—melanoma	0.000939	0.00189	CcSEcCtD
Bexarotene—Hyponatraemia—Docetaxel—melanoma	0.000937	0.00189	CcSEcCtD
Bexarotene—Erythema—Dactinomycin—melanoma	0.000934	0.00188	CcSEcCtD
Bexarotene—Ill-defined disorder—Bleomycin—melanoma	0.000929	0.00187	CcSEcCtD
Bexarotene—Anaemia—Bleomycin—melanoma	0.000926	0.00187	CcSEcCtD
Bexarotene—Diarrhoea—Vemurafenib—melanoma	0.000923	0.00186	CcSEcCtD
Bexarotene—Migraine—Docetaxel—melanoma	0.000918	0.00185	CcSEcCtD
Bexarotene—Eye disorder—Temozolomide—melanoma	0.000907	0.00183	CcSEcCtD
Bexarotene—Tinnitus—Temozolomide—melanoma	0.000905	0.00182	CcSEcCtD
Bexarotene—Malaise—Bleomycin—melanoma	0.000903	0.00182	CcSEcCtD
Bexarotene—Cardiac disorder—Temozolomide—melanoma	0.000901	0.00182	CcSEcCtD
Bexarotene—Arrhythmia—Carmustine—melanoma	0.000897	0.00181	CcSEcCtD
Bexarotene—Leukopenia—Bleomycin—melanoma	0.000897	0.00181	CcSEcCtD
Bexarotene—Dizziness—Vemurafenib—melanoma	0.000892	0.0018	CcSEcCtD
Bexarotene—Alopecia—Carmustine—melanoma	0.000887	0.00179	CcSEcCtD
Bexarotene—Angiopathy—Temozolomide—melanoma	0.000881	0.00177	CcSEcCtD
Bexarotene—Ataxia—Docetaxel—melanoma	0.000877	0.00177	CcSEcCtD
Bexarotene—Malnutrition—Carmustine—melanoma	0.000874	0.00176	CcSEcCtD
Bexarotene—Erythema—Carmustine—melanoma	0.000874	0.00176	CcSEcCtD
Bexarotene—Cough—Bleomycin—melanoma	0.000874	0.00176	CcSEcCtD
Bexarotene—Chills—Temozolomide—melanoma	0.000871	0.00176	CcSEcCtD
Bexarotene—Dehydration—Docetaxel—melanoma	0.000868	0.00175	CcSEcCtD
Bexarotene—Ill-defined disorder—Dactinomycin—melanoma	0.000867	0.00175	CcSEcCtD
Bexarotene—Anaemia—Dactinomycin—melanoma	0.000863	0.00174	CcSEcCtD
Bexarotene—Liver function test abnormal—Docetaxel—melanoma	0.000861	0.00174	CcSEcCtD
Bexarotene—Vomiting—Vemurafenib—melanoma	0.000858	0.00173	CcSEcCtD
Bexarotene—Alopecia—Temozolomide—melanoma	0.000858	0.00173	CcSEcCtD
Bexarotene—Dry skin—Docetaxel—melanoma	0.000855	0.00172	CcSEcCtD
Bexarotene—Chest pain—Bleomycin—melanoma	0.000853	0.00172	CcSEcCtD
Bexarotene—Myalgia—Bleomycin—melanoma	0.000853	0.00172	CcSEcCtD
Bexarotene—Rash—Vemurafenib—melanoma	0.000851	0.00171	CcSEcCtD
Bexarotene—Dermatitis—Vemurafenib—melanoma	0.00085	0.00171	CcSEcCtD
Bexarotene—Back pain—Carmustine—melanoma	0.000846	0.0017	CcSEcCtD
Bexarotene—Headache—Vemurafenib—melanoma	0.000845	0.0017	CcSEcCtD
Bexarotene—Malnutrition—Temozolomide—melanoma	0.000845	0.0017	CcSEcCtD
Bexarotene—Erythema—Temozolomide—melanoma	0.000845	0.0017	CcSEcCtD
Bexarotene—Discomfort—Bleomycin—melanoma	0.000842	0.0017	CcSEcCtD
Bexarotene—Malaise—Dactinomycin—melanoma	0.000842	0.0017	CcSEcCtD
Bexarotene—Aspartate aminotransferase increased—Docetaxel—melanoma	0.00084	0.00169	CcSEcCtD
Bexarotene—Leukopenia—Dactinomycin—melanoma	0.000836	0.00169	CcSEcCtD
Bexarotene—Dysgeusia—Temozolomide—melanoma	0.000827	0.00167	CcSEcCtD
Bexarotene—Confusional state—Bleomycin—melanoma	0.000824	0.00166	CcSEcCtD
Bexarotene—Alanine aminotransferase increased—Docetaxel—melanoma	0.000823	0.00166	CcSEcCtD
Bexarotene—Oedema—Bleomycin—melanoma	0.000817	0.00165	CcSEcCtD
Bexarotene—Back pain—Temozolomide—melanoma	0.000817	0.00165	CcSEcCtD
Bexarotene—Infection—Bleomycin—melanoma	0.000812	0.00164	CcSEcCtD
Bexarotene—Anaemia—Carmustine—melanoma	0.000808	0.00163	CcSEcCtD
Bexarotene—Dysphagia—Docetaxel—melanoma	0.000806	0.00163	CcSEcCtD
Bexarotene—Agitation—Carmustine—melanoma	0.000803	0.00162	CcSEcCtD
Bexarotene—Nausea—Vemurafenib—melanoma	0.000801	0.00162	CcSEcCtD
Bexarotene—Thrombocytopenia—Bleomycin—melanoma	0.0008	0.00161	CcSEcCtD
Bexarotene—Myalgia—Dactinomycin—melanoma	0.000795	0.0016	CcSEcCtD
Bexarotene—Discomfort—Dactinomycin—melanoma	0.000786	0.00158	CcSEcCtD
Bexarotene—Angina pectoris—Docetaxel—melanoma	0.000785	0.00158	CcSEcCtD
Bexarotene—Ill-defined disorder—Temozolomide—melanoma	0.000784	0.00158	CcSEcCtD
Bexarotene—Leukopenia—Carmustine—melanoma	0.000783	0.00158	CcSEcCtD
Bexarotene—Anaemia—Temozolomide—melanoma	0.000781	0.00157	CcSEcCtD
Bexarotene—Anorexia—Bleomycin—melanoma	0.000779	0.00157	CcSEcCtD
Bexarotene—Agitation—Temozolomide—melanoma	0.000776	0.00156	CcSEcCtD
Bexarotene—Pancytopenia—Docetaxel—melanoma	0.000766	0.00154	CcSEcCtD
Bexarotene—Oedema—Dactinomycin—melanoma	0.000762	0.00154	CcSEcCtD
Bexarotene—Malaise—Temozolomide—melanoma	0.000762	0.00154	CcSEcCtD
Bexarotene—Vertigo—Temozolomide—melanoma	0.000759	0.00153	CcSEcCtD
Bexarotene—Infection—Dactinomycin—melanoma	0.000757	0.00153	CcSEcCtD
Bexarotene—Leukopenia—Temozolomide—melanoma	0.000756	0.00152	CcSEcCtD
Bexarotene—Hypertension—Carmustine—melanoma	0.000755	0.00152	CcSEcCtD
Bexarotene—Neutropenia—Docetaxel—melanoma	0.000754	0.00152	CcSEcCtD
Bexarotene—Palpitations—Temozolomide—melanoma	0.000747	0.0015	CcSEcCtD
Bexarotene—Thrombocytopenia—Dactinomycin—melanoma	0.000746	0.0015	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Bleomycin—melanoma	0.000745	0.0015	CcSEcCtD
Bexarotene—Chest pain—Carmustine—melanoma	0.000744	0.0015	CcSEcCtD
Bexarotene—Myalgia—Carmustine—melanoma	0.000744	0.0015	CcSEcCtD
Bexarotene—Anxiety—Carmustine—melanoma	0.000742	0.0015	CcSEcCtD
Bexarotene—Cough—Temozolomide—melanoma	0.000737	0.00149	CcSEcCtD
Bexarotene—Paraesthesia—Bleomycin—melanoma	0.000734	0.00148	CcSEcCtD
Bexarotene—Weight increased—Docetaxel—melanoma	0.000734	0.00148	CcSEcCtD
Bexarotene—Weight decreased—Docetaxel—melanoma	0.00073	0.00147	CcSEcCtD
Bexarotene—Hypertension—Temozolomide—melanoma	0.000729	0.00147	CcSEcCtD
Bexarotene—Dyspnoea—Bleomycin—melanoma	0.000729	0.00147	CcSEcCtD
Bexarotene—Anorexia—Dactinomycin—melanoma	0.000727	0.00146	CcSEcCtD
Bexarotene—Pneumonia—Docetaxel—melanoma	0.000723	0.00146	CcSEcCtD
Bexarotene—Confusional state—Carmustine—melanoma	0.000719	0.00145	CcSEcCtD
Bexarotene—Arthralgia—Temozolomide—melanoma	0.000719	0.00145	CcSEcCtD
Bexarotene—Myalgia—Temozolomide—melanoma	0.000719	0.00145	CcSEcCtD
Bexarotene—Anxiety—Temozolomide—melanoma	0.000717	0.00144	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000714	0.00144	CcSEcCtD
Bexarotene—Oedema—Carmustine—melanoma	0.000714	0.00144	CcSEcCtD
Bexarotene—Discomfort—Temozolomide—melanoma	0.000711	0.00143	CcSEcCtD
Bexarotene—Decreased appetite—Bleomycin—melanoma	0.000711	0.00143	CcSEcCtD
Bexarotene—Infection—Carmustine—melanoma	0.000709	0.00143	CcSEcCtD
Bexarotene—Neuropathy peripheral—Docetaxel—melanoma	0.000705	0.00142	CcSEcCtD
Bexarotene—Dry mouth—Temozolomide—melanoma	0.000703	0.00142	CcSEcCtD
Bexarotene—Stomatitis—Docetaxel—melanoma	0.000701	0.00141	CcSEcCtD
Bexarotene—Jaundice—Docetaxel—melanoma	0.000701	0.00141	CcSEcCtD
Bexarotene—Pain—Bleomycin—melanoma	0.000699	0.00141	CcSEcCtD
Bexarotene—Conjunctivitis—Docetaxel—melanoma	0.000699	0.00141	CcSEcCtD
Bexarotene—Thrombocytopenia—Carmustine—melanoma	0.000699	0.00141	CcSEcCtD
Bexarotene—Tachycardia—Carmustine—melanoma	0.000696	0.0014	CcSEcCtD
Bexarotene—Confusional state—Temozolomide—melanoma	0.000695	0.0014	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000695	0.0014	CcSEcCtD
Bexarotene—Oedema—Temozolomide—melanoma	0.00069	0.00139	CcSEcCtD
Bexarotene—Infection—Temozolomide—melanoma	0.000685	0.00138	CcSEcCtD
Bexarotene—Anorexia—Carmustine—melanoma	0.00068	0.00137	CcSEcCtD
Bexarotene—Epistaxis—Docetaxel—melanoma	0.000678	0.00137	CcSEcCtD
Bexarotene—Nervous system disorder—Temozolomide—melanoma	0.000676	0.00136	CcSEcCtD
Bexarotene—Thrombocytopenia—Temozolomide—melanoma	0.000675	0.00136	CcSEcCtD
Bexarotene—Feeling abnormal—Bleomycin—melanoma	0.000674	0.00136	CcSEcCtD
Bexarotene—Skin disorder—Temozolomide—melanoma	0.00067	0.00135	CcSEcCtD
Bexarotene—Hyperhidrosis—Temozolomide—melanoma	0.000667	0.00134	CcSEcCtD
Bexarotene—Decreased appetite—Dactinomycin—melanoma	0.000663	0.00134	CcSEcCtD
Bexarotene—Fatigue—Dactinomycin—melanoma	0.000657	0.00132	CcSEcCtD
Bexarotene—Anorexia—Temozolomide—melanoma	0.000657	0.00132	CcSEcCtD
Bexarotene—Pain—Dactinomycin—melanoma	0.000652	0.00131	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Carmustine—melanoma	0.00065	0.00131	CcSEcCtD
Bexarotene—Haemoglobin—Docetaxel—melanoma	0.000649	0.00131	CcSEcCtD
Bexarotene—Rhinitis—Docetaxel—melanoma	0.000647	0.0013	CcSEcCtD
Bexarotene—Body temperature increased—Bleomycin—melanoma	0.000646	0.0013	CcSEcCtD
Bexarotene—Haemorrhage—Docetaxel—melanoma	0.000645	0.0013	CcSEcCtD
Bexarotene—Insomnia—Carmustine—melanoma	0.000645	0.0013	CcSEcCtD
Bexarotene—Hypoaesthesia—Docetaxel—melanoma	0.000642	0.00129	CcSEcCtD
Bexarotene—Paraesthesia—Carmustine—melanoma	0.000641	0.00129	CcSEcCtD
Bexarotene—Pharyngitis—Docetaxel—melanoma	0.000641	0.00129	CcSEcCtD
Bexarotene—Urinary tract disorder—Docetaxel—melanoma	0.000637	0.00128	CcSEcCtD
Bexarotene—Dyspnoea—Carmustine—melanoma	0.000636	0.00128	CcSEcCtD
Bexarotene—Oedema peripheral—Docetaxel—melanoma	0.000636	0.00128	CcSEcCtD
Bexarotene—Somnolence—Carmustine—melanoma	0.000634	0.00128	CcSEcCtD
Bexarotene—Connective tissue disorder—Docetaxel—melanoma	0.000634	0.00128	CcSEcCtD
Bexarotene—Urethral disorder—Docetaxel—melanoma	0.000633	0.00128	CcSEcCtD
Bexarotene—Feeling abnormal—Dactinomycin—melanoma	0.000628	0.00127	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Temozolomide—melanoma	0.000628	0.00127	CcSEcCtD
Bexarotene—Insomnia—Temozolomide—melanoma	0.000624	0.00126	CcSEcCtD
Bexarotene—Gastrointestinal pain—Dactinomycin—melanoma	0.000623	0.00126	CcSEcCtD
Bexarotene—Decreased appetite—Carmustine—melanoma	0.00062	0.00125	CcSEcCtD
Bexarotene—Paraesthesia—Temozolomide—melanoma	0.000619	0.00125	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Carmustine—melanoma	0.000616	0.00124	CcSEcCtD
Bexarotene—Dyspnoea—Temozolomide—melanoma	0.000615	0.00124	CcSEcCtD
Bexarotene—Somnolence—Temozolomide—melanoma	0.000613	0.00124	CcSEcCtD
Bexarotene—Pain—Carmustine—melanoma	0.00061	0.00123	CcSEcCtD
Bexarotene—Constipation—Carmustine—melanoma	0.00061	0.00123	CcSEcCtD
Bexarotene—Dyspepsia—Temozolomide—melanoma	0.000607	0.00122	CcSEcCtD
Bexarotene—Eye disorder—Docetaxel—melanoma	0.000603	0.00122	CcSEcCtD
Bexarotene—Body temperature increased—Dactinomycin—melanoma	0.000603	0.00121	CcSEcCtD
Bexarotene—Abdominal pain—Dactinomycin—melanoma	0.000603	0.00121	CcSEcCtD
Bexarotene—Hypersensitivity—Bleomycin—melanoma	0.000602	0.00121	CcSEcCtD
Bexarotene—Decreased appetite—Temozolomide—melanoma	0.000599	0.00121	CcSEcCtD
Bexarotene—Cardiac disorder—Docetaxel—melanoma	0.000599	0.00121	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Temozolomide—melanoma	0.000595	0.0012	CcSEcCtD
Bexarotene—Fatigue—Temozolomide—melanoma	0.000594	0.0012	CcSEcCtD
Bexarotene—Constipation—Temozolomide—melanoma	0.00059	0.00119	CcSEcCtD
Bexarotene—Pain—Temozolomide—melanoma	0.00059	0.00119	CcSEcCtD
Bexarotene—Feeling abnormal—Carmustine—melanoma	0.000588	0.00119	CcSEcCtD
Bexarotene—Asthenia—Bleomycin—melanoma	0.000586	0.00118	CcSEcCtD
Bexarotene—Angiopathy—Docetaxel—melanoma	0.000586	0.00118	CcSEcCtD
Bexarotene—Gastrointestinal pain—Carmustine—melanoma	0.000583	0.00118	CcSEcCtD
Bexarotene—Chills—Docetaxel—melanoma	0.000579	0.00117	CcSEcCtD
Bexarotene—Pruritus—Bleomycin—melanoma	0.000578	0.00117	CcSEcCtD
Bexarotene—Arrhythmia—Docetaxel—melanoma	0.000577	0.00116	CcSEcCtD
Bexarotene—Alopecia—Docetaxel—melanoma	0.00057	0.00115	CcSEcCtD
Bexarotene—Feeling abnormal—Temozolomide—melanoma	0.000568	0.00115	CcSEcCtD
Bexarotene—Body temperature increased—Carmustine—melanoma	0.000564	0.00114	CcSEcCtD
Bexarotene—Abdominal pain—Carmustine—melanoma	0.000564	0.00114	CcSEcCtD
Bexarotene—Gastrointestinal pain—Temozolomide—melanoma	0.000564	0.00114	CcSEcCtD
Bexarotene—Malnutrition—Docetaxel—melanoma	0.000562	0.00113	CcSEcCtD
Bexarotene—Erythema—Docetaxel—melanoma	0.000562	0.00113	CcSEcCtD
Bexarotene—Hypersensitivity—Dactinomycin—melanoma	0.000562	0.00113	CcSEcCtD
Bexarotene—Dysgeusia—Docetaxel—melanoma	0.00055	0.00111	CcSEcCtD
Bexarotene—Asthenia—Dactinomycin—melanoma	0.000547	0.0011	CcSEcCtD
Bexarotene—Abdominal pain—Temozolomide—melanoma	0.000545	0.0011	CcSEcCtD
Bexarotene—Body temperature increased—Temozolomide—melanoma	0.000545	0.0011	CcSEcCtD
Bexarotene—Back pain—Docetaxel—melanoma	0.000543	0.0011	CcSEcCtD
Bexarotene—Muscle spasms—Docetaxel—melanoma	0.00054	0.00109	CcSEcCtD
Bexarotene—Hypersensitivity—Carmustine—melanoma	0.000526	0.00106	CcSEcCtD
Bexarotene—Diarrhoea—Dactinomycin—melanoma	0.000522	0.00105	CcSEcCtD
Bexarotene—Vomiting—Bleomycin—melanoma	0.00052	0.00105	CcSEcCtD
Bexarotene—Anaemia—Docetaxel—melanoma	0.000519	0.00105	CcSEcCtD
Bexarotene—Rash—Bleomycin—melanoma	0.000515	0.00104	CcSEcCtD
Bexarotene—Dermatitis—Bleomycin—melanoma	0.000515	0.00104	CcSEcCtD
Bexarotene—Asthenia—Carmustine—melanoma	0.000512	0.00103	CcSEcCtD
Bexarotene—Hypersensitivity—Temozolomide—melanoma	0.000508	0.00102	CcSEcCtD
Bexarotene—Syncope—Docetaxel—melanoma	0.000504	0.00102	CcSEcCtD
Bexarotene—Leukopenia—Docetaxel—melanoma	0.000503	0.00101	CcSEcCtD
Bexarotene—Palpitations—Docetaxel—melanoma	0.000497	0.001	CcSEcCtD
Bexarotene—Asthenia—Temozolomide—melanoma	0.000495	0.000997	CcSEcCtD
Bexarotene—Loss of consciousness—Docetaxel—melanoma	0.000494	0.000995	CcSEcCtD
Bexarotene—Cough—Docetaxel—melanoma	0.00049	0.000988	CcSEcCtD
Bexarotene—Diarrhoea—Carmustine—melanoma	0.000488	0.000984	CcSEcCtD
Bexarotene—Pruritus—Temozolomide—melanoma	0.000488	0.000983	CcSEcCtD
Bexarotene—Nausea—Bleomycin—melanoma	0.000486	0.000979	CcSEcCtD
Bexarotene—Hypertension—Docetaxel—melanoma	0.000485	0.000978	CcSEcCtD
Bexarotene—Vomiting—Dactinomycin—melanoma	0.000485	0.000977	CcSEcCtD
Bexarotene—Rash—Dactinomycin—melanoma	0.000481	0.000969	CcSEcCtD
Bexarotene—Chest pain—Docetaxel—melanoma	0.000478	0.000964	CcSEcCtD
Bexarotene—Myalgia—Docetaxel—melanoma	0.000478	0.000964	CcSEcCtD
Bexarotene—Arthralgia—Docetaxel—melanoma	0.000478	0.000964	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000475	0.000958	CcSEcCtD
Bexarotene—Dizziness—Carmustine—melanoma	0.000472	0.000951	CcSEcCtD
Bexarotene—Diarrhoea—Temozolomide—melanoma	0.000472	0.000951	CcSEcCtD
Bexarotene—Dry mouth—Docetaxel—melanoma	0.000468	0.000943	CcSEcCtD
Bexarotene—Confusional state—Docetaxel—melanoma	0.000462	0.000932	CcSEcCtD
Bexarotene—Oedema—Docetaxel—melanoma	0.000459	0.000924	CcSEcCtD
Bexarotene—Dizziness—Temozolomide—melanoma	0.000456	0.000919	CcSEcCtD
Bexarotene—Infection—Docetaxel—melanoma	0.000456	0.000918	CcSEcCtD
Bexarotene—Vomiting—Carmustine—melanoma	0.000454	0.000914	CcSEcCtD
Bexarotene—Nausea—Dactinomycin—melanoma	0.000453	0.000913	CcSEcCtD
Bexarotene—Shock—Docetaxel—melanoma	0.000451	0.000909	CcSEcCtD
Bexarotene—Rash—Carmustine—melanoma	0.00045	0.000907	CcSEcCtD
Bexarotene—Nervous system disorder—Docetaxel—melanoma	0.00045	0.000906	CcSEcCtD
Bexarotene—Dermatitis—Carmustine—melanoma	0.000449	0.000906	CcSEcCtD
Bexarotene—Thrombocytopenia—Docetaxel—melanoma	0.000449	0.000905	CcSEcCtD
Bexarotene—Tachycardia—Docetaxel—melanoma	0.000448	0.000902	CcSEcCtD
Bexarotene—Headache—Carmustine—melanoma	0.000447	0.000901	CcSEcCtD
Bexarotene—Skin disorder—Docetaxel—melanoma	0.000445	0.000898	CcSEcCtD
Bexarotene—Vomiting—Temozolomide—melanoma	0.000438	0.000884	CcSEcCtD
Bexarotene—Anorexia—Docetaxel—melanoma	0.000437	0.000881	CcSEcCtD
Bexarotene—Rash—Temozolomide—melanoma	0.000435	0.000876	CcSEcCtD
Bexarotene—Dermatitis—Temozolomide—melanoma	0.000434	0.000876	CcSEcCtD
Bexarotene—Headache—Temozolomide—melanoma	0.000432	0.000871	CcSEcCtD
Bexarotene—Nausea—Carmustine—melanoma	0.000424	0.000854	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Docetaxel—melanoma	0.000418	0.000842	CcSEcCtD
Bexarotene—Insomnia—Docetaxel—melanoma	0.000415	0.000836	CcSEcCtD
Bexarotene—Paraesthesia—Docetaxel—melanoma	0.000412	0.00083	CcSEcCtD
Bexarotene—Nausea—Temozolomide—melanoma	0.00041	0.000826	CcSEcCtD
Bexarotene—Dyspnoea—Docetaxel—melanoma	0.000409	0.000824	CcSEcCtD
Bexarotene—Somnolence—Docetaxel—melanoma	0.000408	0.000822	CcSEcCtD
Bexarotene—Dyspepsia—Docetaxel—melanoma	0.000404	0.000814	CcSEcCtD
Bexarotene—Decreased appetite—Docetaxel—melanoma	0.000399	0.000803	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Docetaxel—melanoma	0.000396	0.000798	CcSEcCtD
Bexarotene—Fatigue—Docetaxel—melanoma	0.000395	0.000797	CcSEcCtD
Bexarotene—Pain—Docetaxel—melanoma	0.000392	0.00079	CcSEcCtD
Bexarotene—Constipation—Docetaxel—melanoma	0.000392	0.00079	CcSEcCtD
Bexarotene—Feeling abnormal—Docetaxel—melanoma	0.000378	0.000762	CcSEcCtD
Bexarotene—Gastrointestinal pain—Docetaxel—melanoma	0.000375	0.000756	CcSEcCtD
Bexarotene—Body temperature increased—Docetaxel—melanoma	0.000362	0.000731	CcSEcCtD
Bexarotene—Abdominal pain—Docetaxel—melanoma	0.000362	0.000731	CcSEcCtD
Bexarotene—Hypersensitivity—Docetaxel—melanoma	0.000338	0.000681	CcSEcCtD
Bexarotene—Asthenia—Docetaxel—melanoma	0.000329	0.000663	CcSEcCtD
Bexarotene—Pruritus—Docetaxel—melanoma	0.000324	0.000654	CcSEcCtD
Bexarotene—Diarrhoea—Docetaxel—melanoma	0.000314	0.000632	CcSEcCtD
Bexarotene—Dizziness—Docetaxel—melanoma	0.000303	0.000611	CcSEcCtD
Bexarotene—Vomiting—Docetaxel—melanoma	0.000292	0.000588	CcSEcCtD
Bexarotene—Rash—Docetaxel—melanoma	0.000289	0.000583	CcSEcCtD
Bexarotene—Dermatitis—Docetaxel—melanoma	0.000289	0.000582	CcSEcCtD
Bexarotene—Headache—Docetaxel—melanoma	0.000287	0.000579	CcSEcCtD
Bexarotene—Nausea—Docetaxel—melanoma	0.000272	0.000549	CcSEcCtD
Bexarotene—RXRG—Generic Transcription Pathway—PPARG—melanoma	0.000252	0.000819	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—NOTCH1—melanoma	0.000251	0.000816	CbGpPWpGaD
Bexarotene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	0.000244	0.000791	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—PAX6—melanoma	0.000243	0.000787	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	0.00024	0.00078	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—CTNNB1—melanoma	0.000238	0.000774	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—PPARG—melanoma	0.000237	0.00077	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	0.000236	0.000766	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—CDKN1A—melanoma	0.000233	0.000756	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	0.000228	0.000741	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—HDAC2—melanoma	0.000224	0.000726	CbGpPWpGaD
Bexarotene—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	0.000219	0.000711	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	0.000217	0.000705	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	0.000216	0.0007	CbGpPWpGaD
Bexarotene—CYP2C9—Arachidonic acid metabolism—PTGS2—melanoma	0.000214	0.000693	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—HDAC2—melanoma	0.00021	0.000683	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—CYP17A1—melanoma	0.00021	0.00068	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—STAT3—melanoma	0.000208	0.000674	CbGpPWpGaD
Bexarotene—CYP2C9—Metapathway biotransformation—CYP17A1—melanoma	0.000207	0.000671	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	0.000206	0.000669	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	0.000203	0.000659	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PLCB4—melanoma	0.000203	0.000659	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	0.0002	0.00065	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—FASN—melanoma	0.000199	0.000646	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	0.000196	0.000635	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—AKT3—melanoma	0.000196	0.000635	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—ITGAV—melanoma	0.000196	0.000635	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—RPS3—melanoma	0.000195	0.000632	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—SNRPE—melanoma	0.000192	0.000622	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—SKI—melanoma	0.000192	0.000622	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PIP4K2A—melanoma	0.000191	0.000619	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—SLC6A11—melanoma	0.000191	0.000619	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—SLC5A5—melanoma	0.000186	0.000605	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—MTAP—melanoma	0.000186	0.000602	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	0.000185	0.000602	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—CDKN2B—melanoma	0.000182	0.00059	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	0.000182	0.00059	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	0.000181	0.000589	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—TNF—melanoma	0.00018	0.000584	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—CDKN2B—melanoma	0.000179	0.00058	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—ITGB1—melanoma	0.000178	0.000576	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—VDR—melanoma	0.000177	0.000576	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	0.000177	0.000574	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—CYP1B1—melanoma	0.000176	0.000572	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	0.000175	0.000569	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—VDR—melanoma	0.000174	0.000566	CbGpPWpGaD
Bexarotene—CYP2C9—Metapathway biotransformation—CYP1B1—melanoma	0.000174	0.000565	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	0.000171	0.000555	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	0.000171	0.000554	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	0.00017	0.000552	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—CDKN2B—melanoma	0.000168	0.000545	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PHGDH—melanoma	0.000165	0.000537	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—LUM—melanoma	0.000165	0.000537	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—VDR—melanoma	0.000164	0.000532	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—HPSE—melanoma	0.000162	0.000527	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—PRKCA—melanoma	0.000161	0.000522	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	0.00016	0.000519	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—ERCC2—melanoma	0.000159	0.000517	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CUBN—melanoma	0.000159	0.000517	CbGpPWpGaD
Bexarotene—CYP3A4—Tryptophan metabolism—MDM2—melanoma	0.000156	0.000507	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	0.000154	0.000501	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—ITGB3—melanoma	0.000154	0.0005	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CSPG4—melanoma	0.000154	0.000499	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—SDHD—melanoma	0.000154	0.000499	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—BSG—melanoma	0.000154	0.000499	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—PRKCA—melanoma	0.000151	0.00049	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MAP2K2—melanoma	0.000151	0.000488	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—NPPA—melanoma	0.00015	0.000487	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—ERCC2—melanoma	0.00015	0.000486	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GPAM—melanoma	0.000149	0.000483	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	0.000146	0.000474	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—IL6—melanoma	0.000145	0.000471	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—MYC—melanoma	0.000144	0.000467	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—RAC1—melanoma	0.000143	0.000463	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—ABCB1—melanoma	0.000142	0.000461	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—MYC—melanoma	0.000142	0.000461	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	0.000139	0.000451	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	0.000139	0.00045	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—CYP17A1—melanoma	0.000138	0.000449	CbGpPWpGaD
Bexarotene—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	0.000136	0.000442	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—MYC—melanoma	0.000135	0.000439	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CUBN—melanoma	0.000134	0.000433	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—TNF—melanoma	0.000132	0.000429	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	0.000131	0.000426	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—NOTCH1—melanoma	0.000131	0.000425	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—KDR—melanoma	0.000131	0.000425	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—NOTCH1—melanoma	0.000129	0.000418	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MET—melanoma	0.000128	0.000416	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—CDK4—melanoma	0.000128	0.000416	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PLA2G6—melanoma	0.000127	0.000411	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—GPAM—melanoma	0.000125	0.000405	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—PPARG—melanoma	0.000124	0.000401	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—NOTCH1—melanoma	0.000123	0.0004	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—PPARG—melanoma	0.000122	0.000394	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—NOTCH1—melanoma	0.000121	0.000393	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	0.00012	0.000391	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ACER3—melanoma	0.000118	0.000382	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—TP53—melanoma	0.000117	0.000378	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—PPARG—melanoma	0.000116	0.000378	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—CYP1B1—melanoma	0.000116	0.000378	CbGpPWpGaD
Bexarotene—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	0.000115	0.000372	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—PPARG—melanoma	0.000114	0.000371	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—VCAN—melanoma	0.000114	0.000369	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—HDAC2—melanoma	0.00011	0.000356	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	0.000108	0.00035	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—UGT2B10—melanoma	0.000108	0.000349	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MMP2—melanoma	0.000107	0.000347	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MAP2K1—melanoma	0.000107	0.000346	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	0.000106	0.000345	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PPARG—melanoma	0.000104	0.000337	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—FGF2—melanoma	0.000102	0.000329	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—HS3ST5—melanoma	0.0001	0.000324	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	9.84e-05	0.000319	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CYP17A1—melanoma	9.6e-05	0.000312	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	9.47e-05	0.000307	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—ERBB2—melanoma	9.36e-05	0.000304	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—ALB—melanoma	9.35e-05	0.000303	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GNA11—melanoma	9.07e-05	0.000294	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—ALB—melanoma	8.89e-05	0.000288	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—FASN—melanoma	8.87e-05	0.000288	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—CDKN2B—melanoma	8.76e-05	0.000284	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—SLC5A5—melanoma	8.73e-05	0.000283	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—VDR—melanoma	8.54e-05	0.000277	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GNAQ—melanoma	8.43e-05	0.000274	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CD44—melanoma	8.43e-05	0.000274	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	8.25e-05	0.000268	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—CTNNB1—melanoma	8.19e-05	0.000266	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PTGS2—melanoma	8.18e-05	0.000265	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CYP1B1—melanoma	8.08e-05	0.000262	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	8.05e-05	0.000261	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MMP9—melanoma	8.03e-05	0.000261	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—NFKB1—melanoma	7.95e-05	0.000258	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—PRKCA—melanoma	7.88e-05	0.000256	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—ERCC2—melanoma	7.81e-05	0.000253	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ACER3—melanoma	7.76e-05	0.000252	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PLCB4—melanoma	7.58e-05	0.000246	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—FASN—melanoma	7.44e-05	0.000241	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—VEGFA—melanoma	7.21e-05	0.000234	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—STAT3—melanoma	7.14e-05	0.000232	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PTEN—melanoma	7.13e-05	0.000231	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PIP4K2A—melanoma	7.12e-05	0.000231	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SLC6A11—melanoma	7.12e-05	0.000231	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—NRAS—melanoma	7.12e-05	0.000231	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—MAPK3—melanoma	7.12e-05	0.000231	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—UGT2B10—melanoma	7.09e-05	0.00023	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—MYC—melanoma	7.05e-05	0.000229	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—MTAP—melanoma	6.93e-05	0.000225	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—MYC—melanoma	6.93e-05	0.000225	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MAPK3—melanoma	6.82e-05	0.000221	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	6.77e-05	0.00022	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—MAPK3—melanoma	6.7e-05	0.000217	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ABCB1—melanoma	6.65e-05	0.000216	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—HS3ST5—melanoma	6.59e-05	0.000214	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—MYC—melanoma	6.51e-05	0.000211	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MAPK1—melanoma	6.49e-05	0.000211	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—EGFR—melanoma	6.49e-05	0.000211	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—NOTCH1—melanoma	6.31e-05	0.000205	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—TNF—melanoma	6.18e-05	0.000201	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—LUM—melanoma	6.18e-05	0.0002	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PHGDH—melanoma	6.18e-05	0.0002	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—KRAS—melanoma	6.13e-05	0.000199	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PRKCA—melanoma	6.12e-05	0.000199	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ERCC2—melanoma	6.07e-05	0.000197	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—HPSE—melanoma	6.06e-05	0.000197	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—PPARG—melanoma	5.95e-05	0.000193	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CUBN—melanoma	5.95e-05	0.000193	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SDHD—melanoma	5.74e-05	0.000186	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CSPG4—melanoma	5.74e-05	0.000186	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—BSG—melanoma	5.74e-05	0.000186	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GPAM—melanoma	5.56e-05	0.00018	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—HRAS—melanoma	5.21e-05	0.000169	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.03e-05	0.000163	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PLCB4—melanoma	5e-05	0.000162	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—IL6—melanoma	4.99e-05	0.000162	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—AKT1—melanoma	4.8e-05	0.000156	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PIK3CG—melanoma	4.8e-05	0.000156	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PLA2G6—melanoma	4.73e-05	0.000153	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SLC6A11—melanoma	4.7e-05	0.000152	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PIP4K2A—melanoma	4.7e-05	0.000152	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PPARG—melanoma	4.63e-05	0.00015	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—AKT1—melanoma	4.6e-05	0.000149	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—MTAP—melanoma	4.57e-05	0.000148	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—AKT1—melanoma	4.52e-05	0.000147	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—VCAN—melanoma	4.25e-05	0.000138	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PIK3CD—melanoma	4.22e-05	0.000137	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ALB—melanoma	4.16e-05	0.000135	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PHGDH—melanoma	4.07e-05	0.000132	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—LUM—melanoma	4.07e-05	0.000132	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	4.02e-05	0.00013	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—HPSE—melanoma	4e-05	0.00013	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CUBN—melanoma	3.92e-05	0.000127	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	3.88e-05	0.000126	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SDHD—melanoma	3.79e-05	0.000123	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CSPG4—melanoma	3.79e-05	0.000123	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—BSG—melanoma	3.79e-05	0.000123	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PIK3CB—melanoma	3.68e-05	0.000119	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GPAM—melanoma	3.67e-05	0.000119	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PTGS2—melanoma	3.64e-05	0.000118	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYP17A1—melanoma	3.58e-05	0.000116	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	3.54e-05	0.000115	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—MAPK3—melanoma	3.49e-05	0.000113	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	3.49e-05	0.000113	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—MYC—melanoma	3.39e-05	0.00011	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GNA11—melanoma	3.38e-05	0.00011	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—FASN—melanoma	3.31e-05	0.000107	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SLC5A5—melanoma	3.26e-05	0.000106	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PTEN—melanoma	3.18e-05	0.000103	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CD44—melanoma	3.15e-05	0.000102	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GNAQ—melanoma	3.15e-05	0.000102	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PLA2G6—melanoma	3.12e-05	0.000101	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	3.08e-05	0.0001	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	3.05e-05	9.91e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYP1B1—melanoma	3.02e-05	9.79e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—VCAN—melanoma	2.8e-05	9.09e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.66e-05	8.64e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ABCB1—melanoma	2.48e-05	8.06e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYP17A1—melanoma	2.36e-05	7.67e-05	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—AKT1—melanoma	2.35e-05	7.64e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PRKCA—melanoma	2.29e-05	7.42e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ERCC2—melanoma	2.27e-05	7.36e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PIK3CA—melanoma	2.24e-05	7.27e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GNA11—melanoma	2.23e-05	7.24e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—FASN—melanoma	2.18e-05	7.09e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SLC5A5—melanoma	2.15e-05	6.97e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GNAQ—melanoma	2.08e-05	6.73e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CD44—melanoma	2.08e-05	6.73e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYP1B1—melanoma	1.99e-05	6.46e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.88e-05	6.1e-05	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—AKT1—melanoma	1.83e-05	5.94e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PIK3CG—melanoma	1.79e-05	5.81e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PPARG—melanoma	1.73e-05	5.61e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ABCB1—melanoma	1.64e-05	5.32e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PIK3CD—melanoma	1.57e-05	5.11e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ALB—melanoma	1.55e-05	5.04e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PRKCA—melanoma	1.51e-05	4.89e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ERCC2—melanoma	1.5e-05	4.85e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PIK3CB—melanoma	1.37e-05	4.45e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PTGS2—melanoma	1.36e-05	4.41e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PTEN—melanoma	1.19e-05	3.85e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PIK3CG—melanoma	1.18e-05	3.83e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PPARG—melanoma	1.14e-05	3.7e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PIK3CD—melanoma	1.04e-05	3.37e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ALB—melanoma	1.02e-05	3.33e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PIK3CB—melanoma	9.05e-06	2.94e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PTGS2—melanoma	8.97e-06	2.91e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PIK3CA—melanoma	8.37e-06	2.71e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PTEN—melanoma	7.82e-06	2.54e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—AKT1—melanoma	6.83e-06	2.22e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PIK3CA—melanoma	5.52e-06	1.79e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—AKT1—melanoma	4.51e-06	1.46e-05	CbGpPWpGaD
